Lic India Login

Jan 29, 2016 at 10:29 | Source: CNBC-TV18
Sources say, if a shareholder has one share of Cairn India then he is entitled to one share of Vedanta and four preference shares of Vedanta.
Jan 27, 2016 at 09:56 | Source: CNBC-TV18
CNBC-TV18's Udayan Mukherjee says the trend is on the way down with periodic upmoves.
Jan 27, 2016 at 08:07 | Source: CNBC-TV18
Vishal Malkan of is of the view that one may buy Steel Authority of India with a target of Rs 47.
Jan 25, 2016 at 19:05 | Source: CNBC-TV18
Mayuresh Joshi of Angel Broking likes LIC Housing from midcap space.
Jan 22, 2016 at 09:57 | Source: CNBC-TV18
Manish Sharma of is of the view that one may buy Axis Bank with a target of Rs 425.
Jan 20, 2016 at 10:27 | Source: CNBC-TV18
According to Damani, nothing in the economy suggests that the boom which started in 2013 is over. He says India is heading into a period of lower interest rates and that will add heft to economic growth and corporate earnings
Jan 19, 2016 at 14:36 | Source: CNBC-TV18
Chandan Taparia, Derivative & Technical Analyst at Anand Rathi Securities is of the view that one can buy Tata Motors futures with a target of Rs 365-370.
Jan 18, 2016 at 15:14 | Source: CNBC-TV18
Gaurav Bissa of LKP Securities recommends going long in LIC Housing Finance and Apollo Hospitals.
Jan 18, 2016 at 08:41 | Source: CNBC-TV18
Stocks likely to be in the focus are: Wockhardt, Titan Company, Aurobindo Pharma, Natco Pharma, Oberoi Realty, LIC Housing Finance, Karnataka Bank, Pipavav Defence and Offshore Engineering Company, Mahindra Holidays and Resorts India, Hindustan Petroleum Corporation, Jet Airways.
Jan 18, 2016 at 07:58 | Source: CNBC-TV18
Wipro | SBI | Kotak Mahindra Bank | United Spirits | MT Educare | Jammu & Kashmir Bank | Oberoi Realty | Indian Hotels | Pipavav Defence | Wockhardt | Marksans Pharma and Bank of India are stocks, which are in the news today.
Explore Moneycontrol

Copyright © Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of is prohibited.